07-28-2015, 05:47 PM
(07-28-2015, 03:24 PM)EricL Wrote: Blowout earnings once again.
- Gilead Sciences (NASDAQ:GILD): Q2 EPS of $3.15 beats by $0.44.
- Revenue of $8.2B (+25.6% Y/Y) beats by $590M.
- Press Release
The most rudimentary of extrapolations has an 11 year P/E ratio average of 23.9 for GILD. At 3.15 * 4 * 23.9 that's a price of $301.25. Which would also make it a $446.5B market cap company
Seems there should be significant upside even if those lofty prices aren't reached.